Bafilomycin C1

Cat. No.: IBDI-430217

Bafilomycin C1 is a macrolide antibiotic isolated from Streptomyces sp. Bafilomycin C1 is a potent, specific and reversible inhibitor of vacuolar-type H +-ATPases (V-ATPases). Bafilomycin C1 inhibits growth of gram-positive bacteria and fungi. Bafilomycin C1 induces cell apoptosis and can be used for the study of hepatocellular carcinoma (HCC).

Product Details

Target	Bacterial | Fungal | Na+/K+ ATPase | Apoptosis | Antibiotic
Molecular Weight	720.89
Appearance	Solid
SMILES	C[[email protected]]([[email protected]@](C[[email protected]]([[email protected]@H]1C)OC(/C=C/C(O)=O)=O)(O[[email protected]@H]1C(C)C)O)[[email protected]](O)[[email protected]@H]([[email protected]](OC(/C(OC)=C/C(C)=C/[[email protected]]2C)=O)([H])[[email protected]](/C=C/C=C(C[[email protected]@H]([[email protected]@H]2O)C)\C)OC)C
Structure Classification	Antibiotics>Macrolide Antibiotics
Purity	≥99.0%

Storage & Handling

Shipping	Room temperature in continental US. May vary elsewhere.
Storage	Please store the product under the recommended conditions in the Certificate of Analysis.
Regulatory Status	This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use.